Biotech industry growth to slow
19 June 2008
Eklavya Gupte, London
The biotech industry is set to slow down because of funding pressures and competition from biosimilars, according to two reports launched this week
The IMS 2008 Global Biotech Perspective report published on June 17 by IMS Health says that global prescription sales of biotech drugs increased 12.5% in 2007 to more than $75 billion.
The report also noted that the global biotech market grew at nearly double the rate of the global pharmaceutical market, which increased 6.4% in 2007.
Murray Aitken, senior vice president, Healthcare...
Only subscribers have complete access to Managing IP Magazine,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial